Register information Patent

DE file number : 60 2007 055 908.1 (Status: pending/in force, Query started: December 17, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INID	Criterion	Field	Content
	Type of IP right	SART	Patent
	Status	ST	Pending/in force
21	DE file number	DAKZ	60 2007 055 908.1
96	EP file number	EAKZ	13 16 4403.1
97	EP publication number	EPN	2662091
54	Designation/title	TI	Anti-P-Selektin-Antikörper und Verfahren zu ihrer Verwendung für die Behandlung von Entzündungserkrankungen
51	IPC main class	ICM (ICMV)	A61K 39/395 (2006.01)
51	IPC secondary class(es)	ICS (ICSV)	C07K 16/28 (2006.01)
22	DE application date	DAT	Nov 30, 2007
96	EP application date	EAT	Nov 30, 2007
43	Date of first publication	OT	Nov 13, 2013
	Date of publication of grant	PET	Aug 22, 2018
71/73	Applicant/owner	INH	Novartis AG, Basel, CH; Oklahoma Medical Research Foundation, Oklahoma City, Okla., US
72	Inventor	IN	McEver, Rodger P., Oklahoma City, OK 73120, US; Alvarez, Richard, Edmond, OK 73013, US; Kawar, Ziad, Oklahoma City, OK 73112, US
	Address for service		Novartis AG, 4056 BASEL, CH
33 31 32	Foreign priority	PRC PRNA PRDA	US 872170 P Dec 1, 2006
	Due date	FT FG	Nov 30, 2026 Annual fee for the 20th year Patent fees
	Patent division in charge		44
21	File number of protection certificate	ZAKZ	12 2021 000 019.4
97	EP language of publication	ELANG	EN - Englisch
84	Designated EP contracting states	EDS	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR
	Published EP/WO documents	EPWOPN	Original document: EP000002662091 Searchable text: EP000002662091 Original document: EP000002662091B1 Searchable text: EP000002662091B1
43	Date of first publication	EVT	Nov 13, 2013
	Date of the first transfer into DPMAregister	EREGT	Dec 25, 2013
	Date of the (most recent) update in DPMAregister	REGT	Oct 30, 2025 (Show all update days)(Hide all update days) Oct 30, 2025 Due date: changed Procedures: Procedure relating to EP application, EPO publication of mention of grant , 22.08.2018: new Procedures: Procedure relating to EP application, EPO publication of mention of grant , 22.08.2018: deleted Oct 30, 2024 Due date: changed Oct 21, 2023; Jul 6, 2022; Oct 22, 2021; May 25, 2021; May 20, 2021; Apr 14, 2021; Nov 24, 2020; Nov 26, 2019; Aug 14, 2019; Jul 11, 2019; Nov 29, 2018; Sep 20, 2018; Aug 11, 2018; Aug 9, 2018; Apr 6, 2017 Historical data not available for this/these date(s) Dec 25, 2013 Date of the first transfer into DPMAregister

Procedural data
No.	Kind of procedure	Legal status	Date of legal/procedural status	Date of first publication	Alle Details anzeigen
1	Procedure relating to EP application	EPO 1st publication	Nov 13, 2013		Details anzeigen
2	Publications	Publication of a mention regarding EP 1st publication by DPMA	Dec 24, 2013	Dec 24, 2013	Details anzeigen
3	Procedure relating to EP application	EPO publication of mention regarding patent grant (beginning of opposition period)	Aug 22, 2018		Details anzeigen
4	Publications	Publication by DPMA of mention regarding EP patent grant	Sep 20, 2018	Sep 20, 2018	Details anzeigen
5	Procedure relating to EP application	No opposition to patent grant filed, or opposition proceedings at EPO completed without decision	May 23, 2019	Aug 14, 2019	Details anzeigen
6	New applicant/owner details	New applicant/owner details	Apr 13, 2021	May 20, 2021	Details anzeigen

View procedures Procedure relating to EP application (No.: 1)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to EP application
Legal/procedural status	VST	EPO 1st publication
Date of legal/procedural status	VSTT	Nov 13, 2013

View procedures Publications (No.: 2)
Criterion	Field	Content Close details
Type of procedure	VART	Publications
Legal/procedural status	VST	Publication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural status	VSTT	Dec 24, 2013
Issue number	HN	52
Year	PJ	2013
Publication date	VT	Dec 24, 2013
Type of publication	PART	Bibliographic data

View procedures Procedure relating to EP application (No.: 3)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to EP application
Legal/procedural status	VST	EPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural status	VSTT	Aug 22, 2018
Date of update of the procedure	REGT	Oct 30, 2025

View procedures Publications (No.: 4)
Criterion	Field	Content Close details
Type of procedure	VART	Publications
Legal/procedural status	VST	Publication by DPMA of mention regarding EP patent grant
Date of legal/procedural status	VSTT	Sep 20, 2018
Issue number	HN	38
Year	PJ	2018
Publication date	VT	Sep 20, 2018
Type of publication	PART	Bibliographic data
Part	HT	Part 5

View procedures Procedure relating to EP application (No.: 5)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to EP application
Legal/procedural status	VST	No opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural status	VSTT	May 23, 2019
Issue number	HN	33
Year	PJ	2019
Publication date	VT	Aug 14, 2019
Type of publication	PART	Bibliographic data
Part	HT	Part 3

View procedures New applicant/owner details (No.: 6)
INID	Criterion	Field	Content Close details
	Type of procedure	VART	New applicant/owner details
	Legal/procedural status	VST	New applicant/owner details
	Date of legal/procedural status	VSTT	Apr 13, 2021
	Issue number	HN	20
	Year	PJ	2021
	Publication date	VT	May 20, 2021
	Type of publication	PART	Bibliographic data
	Part	HT	Part 3
71/73	Applicant/owner	INH	Novartis AG, Basel, CH; Oklahoma Medical Research Foundation, Oklahoma City, Okla., US
71/73	Previous applicant/owner	INHF	Selexys Pharmaceuticals Corporation, Oklahoma City, Okla., US
	Date of update of the procedure	REGT	May 20, 2021